ELEMENTS BG SM CP ET (BSC) 0.00

Trade BSC
NOW!
Last Trade:11.7515Short Ratio:
Last Trade Time:4:00pmDay Range:N/A - N/A
Ask:Year Range:5.50 - 12.83
Bid:One Year Target:
Open:Exchange:PCX
Volume:0EBITDA:0
Prev. Close:11.7515Market Cap:
50 Day Moving:10.9619Div Yield:
200 day moving:10.4672PE:

Genmab Announces Results From Zalutumumab Phase III Study of Refractory Head and Neck Cancer Patients

Posted on 03/08/10 at 9:54am
COPENHAGEN, Denmark, March 8, 2010 (GLOBE NEWSWIRE) -- Summary: Genmab announces top-line results from a study of zalutumumab in refractory head and neck cancer patients who failed platinum-based chemotherapy.
Click here to read the rest of the article

Payer-Provider Transparency, Powered by MedeAnalytics, Eliminates Administrative Costs from Healthcare

Posted on 03/01/10 at 8:12am
EMERYVILLE, Calif.--(BUSINESS WIRE)-- MedeAnalytics, a leading provider of healthcare performance management solutions, reported at HIMSS10 in Atlanta, Ga., that Blue Shield of California’s innovative Partnership in Operational Excellence and Transparency (POET) program, utilizing MedeAnalytics’
Click here to read the rest of the article

Blue Shield of California Extends Contract for MedeAnalytics’ Claims Transparency Solution

Posted on 02/12/10 at 8:04am
EMERYVILLE, Calif.--(BUSINESS WIRE)-- MedeAnalytics, a leading provider of healthcare performance management solutions, announced that Blue Shield of California (BSC) has extended its agreement for MedeAnalytics’ Claims Transparency solution, which powers BSC’s successful Partnership in Operatio
Click here to read the rest of the article